RxDoctor Payments Data

Stephanie Jones, MD

Interventional Pain Medicine · Dallas, TXNPI 1003073941

Payments from drug & device makers

$7,033in general payments, 2019–2025

Across 76 payments — averaging $92.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$1K
  • Nevro Corp.$1K
  • SPR Therapeutics, Inc$997
  • Globus Medical$768
  • Foundation Fusion Solutions, LLC$587
  • Stratus Medical, LLC$322
  • plus $2K from 16 others

What the payments were for

  • Travel & lodging$1,72325%
  • Food & beverage$5,31075%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,033 in reported general payments places this provider in the 45th percentile of 287 interventional pain medicine providers in Texas.

See all interventional pain medicine providers in Texas

Medicare billing

Part B allowed, 2024
$74,248
Medicare patients
249
Services billed
679

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin206$4,729
Gabapentin326$4,711
Duloxetine Hcl196$3,400
Lidocaine15$2,488
Baclofen97$2,361
Methocarbamol141$1,883
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen53$1,293
Tizanidine Hcl74$1,011
Cyclobenzaprine Hcl28$557
Tramadol Hcl46$439
Celecoxib28$415
Memantine Hcl19$395
Nabumetone17$269
Topiramate34$131
Meloxicam41$114

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →